For sufferers with eosinophilic granulomatosis with polyangiitis (EGPA), rituximab shouldn’t be superior to the standard remission induction technique, in accordance…
Read More
For sufferers with eosinophilic granulomatosis with polyangiitis (EGPA), rituximab shouldn’t be superior to the standard remission induction technique, in accordance…
Read More